Selank and Tuftsin-Family Peptides Help Different Personality Types Handle Stress Differently

Selank and related tuftsin-family peptides improved adaptive behavior in stressed animals, with effects varying by the animal's baseline emotional phenotype — anxious versus bold animals responded to different peptides.

Kozlovskaya, M M et al.·Neuroscience and behavioral physiology·2003·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-00837Animal StudyPreliminary Evidence2003RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Selank and tuftsin-family peptides improved adaptive behavior in stressed animals in a phenotype-dependent manner, with different peptides optimal for different emotional reactivity types — supporting personalized peptide anxiolytic therapy.

Key Numbers

How They Did This

Animal behavioral study comparing Selank and tuftsin-family peptides in rats and mice pre-classified by emotional reactivity phenotype. Stress adaptation behaviors measured across different emotional types.

Why This Research Matters

One-size-fits-all anxiolytics often fail. Matching peptide type to personality/temperament type could improve treatment outcomes — precision psychiatry at the peptide level.

The Bigger Picture

Personalized medicine extends to anxiety treatment. Different molecular subtypes of anxiety may respond to different peptide interventions — matching drug to temperament.

What This Study Doesn't Tell Us

Animal behavioral study. Human temperament is more complex. The molecular basis for phenotype-dependent responses was not determined.

Questions This Raises

  • ?Can human anxiety subtypes be matched to specific peptide anxiolytics?
  • ?What molecular differences underlie the phenotype-dependent responses?
  • ?Could temperament testing guide peptide drug selection?

Trust & Context

Key Stat:
Personality-matched therapy Different peptides worked best for different temperament types — anxiety treatment may need to be matched to personality, not one-drug-fits-all
Evidence Grade:
Preliminary animal evidence demonstrating phenotype-dependent drug efficacy across multiple peptides and behavioral tests.
Study Age:
Published in 2003. Personalized approaches to anxiety pharmacotherapy continue to be explored.
Original Title:
Selank and short peptides of the tuftsin family in the regulation of adaptive behavior in stress.
Published In:
Neuroscience and behavioral physiology, 33(9), 853-60 (2003)
Database ID:
RPEP-00837

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Should anxiety treatment be personalized?

This study suggests yes — different anxiety peptides worked better for different personality types. What helps a naturally anxious individual may not help a naturally bold one.

How could this work in practice?

Patients could be assessed for their anxiety subtype (temperament testing), then matched to the peptide most likely to help their specific pattern — like matching blood type to transfusion.

Read More on RethinkPeptides

Cite This Study

RPEP-00837·https://rethinkpeptides.com/research/RPEP-00837

APA

Kozlovskaya, M M; Kozlovskii, I I; Val'dman, E A; Seredenin, S B. (2003). Selank and short peptides of the tuftsin family in the regulation of adaptive behavior in stress.. Neuroscience and behavioral physiology, 33(9), 853-60.

MLA

Kozlovskaya, M M, et al. "Selank and short peptides of the tuftsin family in the regulation of adaptive behavior in stress.." Neuroscience and behavioral physiology, 2003.

RethinkPeptides

RethinkPeptides Research Database. "Selank and short peptides of the tuftsin family in the regul..." RPEP-00837. Retrieved from https://rethinkpeptides.com/research/kozlovskaya-2003-selank-and-short-peptides

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.